Marinus Pharmaceuticals Inc (MRNS)
1.405
-0.02
(-1.06%)
USD |
NASDAQ |
Apr 26, 16:00
1.41
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Max Drawdown (5Y): 94.98% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
March 31, 2024 | 94.98% |
February 29, 2024 | 94.98% |
January 31, 2024 | 94.98% |
December 31, 2023 | 94.98% |
November 30, 2023 | 94.98% |
October 31, 2023 | 94.98% |
September 30, 2023 | 94.98% |
August 31, 2023 | 94.98% |
July 31, 2023 | 94.98% |
June 30, 2023 | 94.98% |
May 31, 2023 | 94.98% |
April 30, 2023 | 94.98% |
March 31, 2023 | 94.98% |
February 28, 2023 | 94.98% |
January 31, 2023 | 94.98% |
December 31, 2022 | 94.98% |
November 30, 2022 | 94.98% |
October 31, 2022 | 94.98% |
September 30, 2022 | 94.98% |
August 31, 2022 | 94.98% |
July 31, 2022 | 94.98% |
June 30, 2022 | 94.98% |
May 31, 2022 | 94.98% |
April 30, 2022 | 94.98% |
March 31, 2022 | 94.98% |
Date | Value |
---|---|
February 28, 2022 | 94.98% |
January 31, 2022 | 94.98% |
December 31, 2021 | 94.98% |
November 30, 2021 | 94.98% |
October 31, 2021 | 94.98% |
September 30, 2021 | 95.69% |
August 31, 2021 | 95.69% |
July 31, 2021 | 95.69% |
June 30, 2021 | 95.69% |
May 31, 2021 | 95.69% |
April 30, 2021 | 95.69% |
March 31, 2021 | 95.69% |
February 28, 2021 | 95.69% |
January 31, 2021 | 95.69% |
December 31, 2020 | 95.69% |
November 30, 2020 | 95.69% |
October 31, 2020 | 95.69% |
September 30, 2020 | 95.69% |
August 31, 2020 | 95.69% |
July 31, 2020 | 95.69% |
June 30, 2020 | 95.69% |
May 31, 2020 | 95.69% |
April 30, 2020 | 95.69% |
March 31, 2020 | 95.69% |
February 29, 2020 | 95.69% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.98%
Minimum
Oct 2021
95.69%
Maximum
Apr 2019
95.34%
Average
95.34%
Median
Max Drawdown (5Y) Benchmarks
Ligand Pharmaceuticals Inc | 77.41% |
Soligenix Inc | 99.21% |
Actinium Pharmaceuticals Inc | 97.29% |
Macrogenics Inc | 93.69% |
ADMA Biologics Inc | 84.77% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -25.46 |
Beta (5Y) | 0.9111 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 93.47% |
Historical Sharpe Ratio (5Y) | -0.1452 |
Historical Sortino (5Y) | -0.2614 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.29% |